Objectives

After participating in this educational activity, attendees should be able to:

1| Get familiarized with the evolution of guidance on the use of aspirin in the prevention of preeclampsia
2| Evaluate the evidence supporting aspirin efficacy in the prevention of various adverse outcomes
3| Evaluate the data behind current controversies regarding aspirin dosing and the identification of at-risk populations

Presenter(s): 

Rupsa C. Boelig, MD MS
Associate Professor
Director of Research, Dept of Ob/Gyn
Associate Program Director, Maternal Fetal Medicine Fellowship
Division of Maternal-Fetal Medicine, Department of Ob/Gyn
Sidney Kimmel Medical College, Thomas Jefferson University

 

 

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Rupsa C. Boelig, MD MSSpeakerPI investigator of a sponsored study by COVIS Pharma (Grant to Thomas Jefferson University)no
Session date: 
02/27/2025 - 8:00am to 9:00am EST
Location: 
Lundy Board Room & Zoom
759 Chestnut St
Springfield, MA 01199
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AAPA Category 1 CME credit
    Baystate Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PA’s should only claim credit commensurate with the extent of their participation.
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC Contact Hours
  • 1.00 IPCE Credit Hour(s)

Please login or register to take this course.